We are live on ! Find out more
BJDX icon

Bluejay Diagnostics

7 hedge funds and large institutions have $259K invested in Bluejay Diagnostics in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

429% more capital inflows, than outflows

Capital inflows: $554K | Capital outflows: $105K

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

17% more funds holding

Funds holding: 6 → 7 (+1)

14.84% more ownership

Funds ownership: 6.05% → 20.89% (+15%)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BJDX Hedge Fund Activity: Q2 2026 in Review

7 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q2 2026, worth a combined $259K — up 140% from $108K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BJDX positions and 4 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $339K. The largest seller was Sabby Management, exiting entirely with an estimated $52.9K sold.

  • 7 institutional investors held Bluejay Diagnostics (BJDX) as of Q2 2026, up from 6 in Q1 2026.
  • Funds reported $259K of Bluejay Diagnostics stock for Q2 2026, up 140% quarter-over-quarter.
  • 5 funds opened new Bluejay Diagnostics positions in Q2 2026 and 4 closed out, a net change of +1 holder.
  • The largest Bluejay Diagnostics buyer in Q2 2026 was Armistice Capital, an estimated $339K added.
  • The largest Bluejay Diagnostics seller in Q2 2026 was Sabby Management, an estimated $52.9K sold.

Based on aggregated 13F filings for Q2 2026.